About Us

Histogen Corporate
Factsheet
Home > About Histogen > News and Events

Latest News

Histogen Signs License Agreement with Suneva Medical for Cell Conditioned Media-based Aesthetic Products

Histogen Wins Motion for Summary Judgment in Patent Case, Defeating SkinMedica's
Claims

Histogen Wins Patent Ruling

David Nassif Joins Histogen as President and CFO

More >>  


Upcoming Events

American Association for Cancer Research (AACR) Annual Meeting
March 31 - April 4, 2012
Chicago, IL
Emmett Pinney to present "A Secreted Tissue Engineered Extracellular Matrix Prevents Recurrence in Post-Resection Pancreatic Cancer Models"

Society for Investigative Dermatology (SID) Annual Meeting
May 9 - 12, 2012
Raleigh, NC
Dr. Gail Naughton to present "Stimulation of hair growth in humans by cell-secreted proteins"
Dr. Jonathan Mansbridge to present "Bioengineered human extracellular matrix for wound healing"

BIO International Convention
June 18 - 21, 2012
Boston, MA
Dr. Gail Naughton presenting in BIO Business Forum

TERMIS World Congress
September 5 - 8, 2012
Vienna, Austria
Dr. Jonathan Mansbridge to present "Stimulation of hair growth in humans by cell-secreted proteins"

International Society of Hair Restoration Surgery (ISHRS) Annual Meeting
October 17 - 20, 2012
Bahamas
Dr. Gail Naughton to present "Scalp Injection of active embryonic-like cell-secreted proteins and growth factors"

Histogen's proprietary tissue-engineering process is utilized for manufacturing all of Histogen's products. Newborn cells are placed into a bioreactor and conditioned with a liquid media.
  • HSC's components have recently been shown to be critical for new hair follicle formation
  • The field of stem cell research is rapidly expanding
  • Histogen scientists have developed regenerative medical technologies without the use of stem cells or animal serum
© Histogen Inc., CA 92121